Our Innovation

BraineHealth’s innovation centers on US Patent 11,908,579 B2, powering our AI diagnostics platform, Diagnosio.

This patented inversion technology achieves 99% accuracy in simulations, outperforming Microsoft’s MAI-DxO with dynamic decision-making.

Born from a 2018 KTH thesis, it scales to 20,000+ cases and 200,000 observables, transforming healthcare.

Featured in USA news, BizWeekly and AP among 450+ outlets, our technology targets the $500B AI market by 2032. Explore licensing today.

License the Patent to integrate our 99% accurate AI technology.

Contact Us to collaborate.